{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:47:48Z","timestamp":1793958468896,"version":"4.8.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejps.2023.106612","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:00:32Z","timestamp":1697364032000},"page":"106612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation"],"prefix":"10.1016","volume":"191","author":[{"given":"Shymaa","family":"Hatem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"El-Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/08982104.2016.1149866","article-title":"Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate","volume":"27","author":"Abdel-Salam","year":"2017","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/10717544.2014.945130","article-title":"Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment","volume":"23","author":"Abidin","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2023.106612_bib0003","doi-asserted-by":"crossref","first-page":"104764","DOI":"10.1016\/j.jddst.2023.104764","article-title":"Augmented efficiency of azithromycin for MRSA ocular infections management: limonene-based nanostructured-lipid carriers in-situ approach","volume":"87","author":"Abla","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.ejps.2023.106612_bib0004","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/10837450.2020.1764032","article-title":"In vitro anti-inflammatory potential of phloretin microemulsion as a new formulation for prospective treatment of vaginitis","volume":"25","author":"Abu-Azzam","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106612_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1166\/jbn.2013.1569","article-title":"Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use","volume":"9","author":"Aggarwal","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106612_bib0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2010.09.007","article-title":"Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"401","author":"Agrawal","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106612_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100123","article-title":"Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis","volume":"10","author":"Alam","year":"2023","journal-title":"OpenNano"},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/scipharm90010014","article-title":"Systematic review on the effectiveness of essential and carrier oils as skin penetration enhancers in pharmaceutical formulations","volume":"90","author":"Alhasso","year":"2022","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejps.2023.106612_bib0009","article-title":"Formulation and optimization of naringin loaded nanostructured lipid carriers using Box-Behnken based design: in vitro and ex vivo evaluation","volume":"74","author":"Alhalmi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106612_bib0010","first-page":"663","article-title":"Preparation and characterization of three tilmicosin-loaded lipid nanoparticles: physicochemical properties and in-vitro antibacterial activities","volume":"15","author":"Al-Qushawi","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-20-76","article-title":"Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (Solanum aethiopicum)","volume":"20","author":"Anosike","year":"2012","journal-title":"DARU J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0012","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/16583655.2020.1812269","article-title":"Formulation, characterization, in vitro and in vivo evaluations of self-nanoemulsifying drug delivery system of luteolin","volume":"14","author":"Ansari","year":"2020","journal-title":"J. Taibah Univ. Sci."},{"issue":"12","key":"10.1016\/j.ejps.2023.106612_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/nano11123433","article-title":"Development and in vitro\/in vivo evaluation of pH-sensitive polymeric nanoparticles loaded hydrogel for the management of psoriasis","volume":"11","author":"Asad","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejps.2023.106612_bib0014","series-title":"Immunity and Inflammation in Health and Disease","first-page":"281","article-title":"Flavonoids in treating psoriasis","author":"Bonesi","year":"2018"},{"issue":"12","key":"10.1016\/j.ejps.2023.106612_bib0015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2174\/0929867323666160321121819","article-title":"Anti-psoriasis agents from natural plant sources","volume":"23","author":"Bonesi","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2\u2013IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Investig. Dermatol."},{"issue":"37","key":"10.1016\/j.ejps.2023.106612_bib0017","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1039\/D2TB00614F","article-title":"Latest on biomaterial-based therapies for topical treatment of psoriasis","volume":"10","author":"Chen","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"11","key":"10.1016\/j.ejps.2023.106612_bib0018","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/mi13111838","article-title":"Drug delivery systems and flavonoids: current knowledge in melanoma treatment and future perspectives","volume":"13","author":"Cunha","year":"2022","journal-title":"Micromachines"},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0019","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s42770-022-00883-2","article-title":"Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals","volume":"54","author":"de Aguiar Cordeiro","year":"2023","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.ejps.2023.106612_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"Di","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2023.106612_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejps.2019.104972","article-title":"Colloidal (-)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: a comprehensive experimental study with preclinical investigation","volume":"137","author":"El-Kayal","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106612_bib0022","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2019.118556","article-title":"Novel antipsoriatic fluidized spanlastic nanovesicles: in vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy","volume":"568","author":"Elmowafy","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0023","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2022.2154122","article-title":"Deucravacitinib in the treatment of psoriasis","volume":"34","author":"Estevinho","year":"2023","journal-title":"J. Dermatol. Treat."},{"issue":"4","key":"10.1016\/j.ejps.2023.106612_bib0024","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10837450.2016.1146294","article-title":"Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma","volume":"22","author":"Fadel","year":"2017","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0025","first-page":"283","article-title":"LED enhances anti-inflammatory effect of luteolin (3\u2032,4\u2032,5,7-tetrahydroxyflavone) in vitro","volume":"10","author":"Fan","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221013804484827","article-title":"Nanostructured lipid carriers (NLCs) for drug delivery and targeting","volume":"7","author":"Fang","year":"2013","journal-title":"Recent Pat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jphotobiol.2011.01.005","article-title":"UV-ABC screens of luteolin derivatives compared to edelweiss extract","volume":"103","author":"Fischer","year":"2011","journal-title":"J. Photochem. Photobiol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","article-title":"Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours","volume":"8","author":"Garg","year":"2022","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106612_bib0029","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2147\/IJN.S29710","article-title":"Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications","volume":"7","author":"Gokce","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2023.106612_bib0030","first-page":"105","article-title":"Nanostructured lipid carriers for the encapsulation of phloretin: preparation and in vitro characterization studies","volume":"25","author":"Gu","year":"2021","journal-title":"Chem. Phys. Lipids"},{"issue":"2","key":"10.1016\/j.ejps.2023.106612_bib0031","article-title":"Guar gum series affect nanostructured lipid carriers via electrostatic assembly or steric hindrance: improving their oral delivery for phytosterols","volume":"253","author":"Guo","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2023.106612_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2014.06.006","article-title":"Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols","volume":"559","author":"Gupta","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/nano11010171","article-title":"The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect","volume":"11","author":"Hallan","year":"2021","journal-title":"Nanomaterials"},{"issue":"9","key":"10.1016\/j.ejps.2023.106612_bib0034","first-page":"146","article-title":"Effect of surfactant and oil type on size droplets of betacarotene-bearing nanoemulsions","volume":"4","author":"Hasani","year":"2015","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"10.1016\/j.ejps.2023.106612_bib0035","first-page":"101","article-title":"Background and different treatment modalities for melasma: conventional and nanotechnology-based approaches","volume":"60","author":"Hatem","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0036","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/10717544.2022.2058652","article-title":"Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment","volume":"29","author":"Hatem","year":"2022","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.ejps.2023.106612_bib0037","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/17425247.2018.1517740","article-title":"Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils","volume":"15","author":"Hatem","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejps.2023.106612_bib0038","first-page":"1","article-title":"Psychological well-being of adult psoriasis patients: a narrative review","volume":"15","author":"Hepat","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejps.2023.106612_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113734","article-title":"Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol","volume":"316","author":"Houacine","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejps.2023.106612_bib0040","first-page":"205","article-title":"Contrast between intermolecular, interparticle, and intersurface forces","volume":"4","author":"Israelachivilbi","year":"2011"},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0041","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jbiosc.2022.06.009","article-title":"Characterization of entrapment behavior of polyphenols in nanostructured lipid carriers and its effect on their antioxidative activity","volume":"134","author":"Izza","year":"2022","journal-title":"J. Biosci. Bioeng."},{"issue":"9","key":"10.1016\/j.ejps.2023.106612_bib0042","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11051-023-05840-0","article-title":"Potential of nanostructured lipid carriers in oral delivery of the poorly soluble drugs","volume":"25","author":"Jiwankar","year":"2023","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ejps.2023.106612_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123271","article-title":"Topical caffeine-loaded nanostructured lipid carriers for enhanced treatment of cellulite: a 32 full factorial design optimization and in vivo evaluation in rats","volume":"643","author":"Kassem","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejps.2023.106612_bib0044","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1208\/s12249-016-0621-0","article-title":"Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability","volume":"18","author":"Kelidari","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"21","key":"10.1016\/j.ejps.2023.106612_bib0045","first-page":"156","article-title":"Solid lipid nanoparticles for topical delivery of meloxicam: development and in vitro characterization","volume":"9","author":"Khalil","year":"2013","journal-title":"Eur. Sci. J."},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0046","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/membranes13030343","article-title":"Potential of lipid-based nanocarriers against two major barriers to drug delivery\u2013skin and blood\u2013brain barrier","volume":"13","author":"Khan","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.ejps.2023.106612_bib0047","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/IJN.S400610","article-title":"Development and optimization of imiquimod-loaded nanostructured lipid carriers using a hybrid design of experiments approach","volume":"18","author":"Kim","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.ejps.2023.106612_bib0048","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/ijd.12870","article-title":"Advances in non-invasive techniques as aids to the diagnosis and monitoring of therapeutic response in plaque psoriasis: a review","volume":"54","author":"Lacarrubba","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejps.2023.106612_bib0049","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.intimp.2019.106070","article-title":"Effects of luteolin on treatment of psoriasis by repressing HSP90","volume":"79","author":"Lv","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1208\/s12249-023-02500-3","article-title":"A full factorial design to optimize aminexil nano lipid formulation to improve skin permeation and efficacy against alopecia","volume":"24","author":"Makky","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2023.106612_bib0051","first-page":"102","article-title":"Enhanced anti-psoriatic activity of tacrolimus loaded nanoemulsion gel via omega 3-Fatty acid (EPA and DHA) rich oils-fish oil and linseed oil","volume":"63","author":"Mittal","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106612_bib0052","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0053","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/10717544.2022.2050847","article-title":"The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis","volume":"29","author":"Motawea","year":"2022","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.ejps.2023.106612_bib0054","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/antiox12061264","article-title":"Tea tree oil: properties and the therapeutic approach to acne\u2013a review","volume":"12","author":"Nascimento","year":"2023","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejps.2023.106612_bib0056","first-page":"89","article-title":"Antipsoriatic effects of wannachawee recipe on imiquimod-induced psoriasis-like dermatitis in BALB\/c mice","volume":"17","author":"Na-Takuathung","year":"2018","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"46","key":"10.1016\/j.ejps.2023.106612_bib0057","doi-asserted-by":"crossref","first-page":"29080","DOI":"10.1039\/D1RA06087B","article-title":"Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects","volume":"11","author":"Nordin","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0058","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ar.23690","article-title":"Effect of topical application of black seed oil on imiquimod-induced psoriasis-like lesions in the thin skin of adult male albino rats","volume":"301","author":"Okasha","year":"2018","journal-title":"Anat. Rec."},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0059","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1208\/s12249-009-9287-1","article-title":"Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery","volume":"10","author":"Pathak","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejps.2023.106612_bib0060","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3390\/ijms24032978","article-title":"Recent advancements in topical anti-psoriatic nanostructured lipid carrier-based drug delivery","volume":"24","author":"Patil","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2023.106612_bib0061","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/pharmaceutics12100973","article-title":"Transcutol\u00ae P containing SLNs for improving 8-methoxypsoralen skin delivery","volume":"12","author":"Pitzanti","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejps.2023.106612_bib0062","first-page":"412","article-title":"Design of besifloxacin HCl-loaded nanostructured lipid carriers: in vitro and ex vivo evaluation","volume":"38","author":"Polat","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0063","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1080\/10717544.2022.2120927","article-title":"Microneedle mediated transdermal delivery of \u03b2-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia","volume":"29","author":"Prabahar","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2023.106612_bib0064","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2015.05.012","article-title":"Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"101","author":"Pradhan","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.ejps.2023.106612_bib0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jddst.2017.07.024","article-title":"Fabrication, optimization and characterization of Triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies","volume":"41","author":"Pradhan","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0066","first-page":"58","article-title":"Development and validation of RP-HPLC method for simultaneous determination of apigenin and luteolin in ethanol extract of Clerodendrum serratum (Linn.) leaves","volume":"5","author":"Rajagopal","year":"2017","journal-title":"Asian J. Appl. Sci."},{"issue":"7","key":"10.1016\/j.ejps.2023.106612_bib0067","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s13346-021-01058-6","article-title":"In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery","volume":"12","author":"Ramzan","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106612_bib0068","article-title":"Deucravacitinb is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis","volume":"188","author":"Roskoski","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106612_bib0069","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chemphyslip.2018.09.007","article-title":"Preparation and characterization of nanostructured lipid carriers as drug delivery system: influence of liquid lipid types on loading and cytotoxicity","volume":"216","author":"Saedi","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2023.106612_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2022.130135","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers of dual functionality at emulsion interfaces. Part I: pickering stabilisation functionality","volume":"654","author":"Sakellari","year":"2022","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejps.2023.106612_bib0071","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4028\/www.scientific.net\/AMR.1060.62","article-title":"Effect of solid lipid and liquid oil ratios on properties of nanostructured lipid carriers for oral curcumin delivery","volume":"1060","author":"Sangsen","year":"2015","journal-title":"Adv. Mater. Res."},{"issue":"24","key":"10.1016\/j.ejps.2023.106612_bib0072","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.3390\/molecules26247497","article-title":"Hepatoprotective effects of bioflavonoid luteolin using self-nanoemulsifying drug delivery system","volume":"26","author":"Shakeel","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106612_bib0073","article-title":"Nanocarriers for targeted drug delivery","volume":"62","author":"Shah","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106612_bib0074","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1007\/s11033-021-06445-3","article-title":"Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments","volume":"48","author":"Smajlovi\u0107","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.ejps.2023.106612_bib0075","first-page":"257","article-title":"Development of tretinoin-loaded nanostructured lipid carrier and hyaluronic acid topical gel","volume":"17","author":"Subramanian","year":"2023","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.ejps.2023.106612_bib0076","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0077","first-page":"44","article-title":"Effect of different lipid ratios on physicochemical stability and drug release of nanostructured lipid carriers loaded coenzyme Q10","volume":"10","author":"Suyuti","year":"2023","journal-title":"J. Ilmu Kesehat. Farm."},{"issue":"6","key":"10.1016\/j.ejps.2023.106612_bib0078","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/biomedicines11061589","article-title":"Pathology and treatment of psoriasis using nanoformulations","volume":"11","author":"Thirumal","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ejps.2023.106612_bib0079","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1021\/acs.jnatprod.2c00720","article-title":"Digital database of absorption spectra of diverse flavonoids enables structural comparisons and quantitative evaluations","volume":"86","author":"Taniguchi","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejps.2023.106612_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jddst.2018.12.026","article-title":"Solid lipid nanoparticles made of trehalose monooleate for cyclosporin-A topic release","volume":"49","author":"Trombino","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.ejps.2023.106612_bib0081","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/ph16081151","article-title":"Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: statistical optimization and pharmacological evaluations","volume":"16","author":"Unnisa","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ejps.2023.106612_bib0082","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13204-015-0434-6","article-title":"Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology","volume":"6","author":"Velmurugan","year":"2016","journal-title":"Appl. Nanosci."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0083","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/08982104.2019.1593449","article-title":"Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis","volume":"30","author":"Walunj","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejps.2023.106612_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.electacta.2022.141534","article-title":"An ultra-sensitive luteolin sensor based on Co-doped nitrogen-containing carbon framework\/MoS2-MWCNTs composite for natural sample detection","volume":"438","author":"Wang","year":"2023","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.ejps.2023.106612_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopha.2018.11.092","article-title":"PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro-and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3","volume":"110","author":"Wu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejps.2023.106612_bib0086","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13197-017-2937-5","article-title":"Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification","volume":"55","author":"Zardini","year":"2018","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.ejps.2023.106612_bib0087","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biopha.2020.110696","article-title":"Luteolin attenuates imiquimod\u2013induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:11:03Z","timestamp":1760530263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":87,"alternative-id":["S0928098723002427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106612","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106612"}}